Leidos (LDOS) Projected to Post Quarterly Earnings on Tuesday

Leidos (NYSE:LDOS - Get Free Report) is anticipated to post its Q1 2025 quarterly earnings results before the market opens on Tuesday, May 6th. Analysts expect Leidos to post earnings of $2.47 per share and revenue of $4.11 billion for the quarter. Leidos has set its FY 2025 guidance at 10.350-10.750 EPS.

Leidos (NYSE:LDOS - Get Free Report) last posted its quarterly earnings data on Tuesday, February 11th. The aerospace company reported $2.37 EPS for the quarter, beating the consensus estimate of $2.24 by $0.13. Leidos had a net margin of 7.53% and a return on equity of 30.93%. On average, analysts expect Leidos to post $11 EPS for the current fiscal year and $11 EPS for the next fiscal year.

Leidos Stock Down 0.3 %

Shares of NYSE:LDOS traded down $0.37 during mid-day trading on Wednesday, reaching $147.19. 1,025,546 shares of the stock were exchanged, compared to its average volume of 1,203,091. Leidos has a one year low of $123.62 and a one year high of $202.90. The company has a quick ratio of 1.13, a current ratio of 1.21 and a debt-to-equity ratio of 0.91. The stock's 50 day simple moving average is $136.67 and its 200-day simple moving average is $150.27. The company has a market cap of $18.87 billion, a P/E ratio of 15.93, a P/E/G ratio of 1.65 and a beta of 0.66.

Leidos Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, March 28th. Investors of record on Friday, March 14th were issued a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 1.09%. The ex-dividend date of this dividend was Friday, March 14th. Leidos's payout ratio is 17.32%.

Analyst Ratings Changes

Several equities research analysts have recently commented on LDOS shares. UBS Group cut their price objective on Leidos from $162.00 to $156.00 and set a "neutral" rating for the company in a report on Wednesday, February 12th. Cantor Fitzgerald raised shares of Leidos to a "strong-buy" rating in a report on Tuesday, February 25th. TD Cowen cut shares of Leidos from a "buy" rating to a "hold" rating and cut their price objective for the stock from $200.00 to $165.00 in a research report on Wednesday, January 8th. Wells Fargo & Company lowered their price target on Leidos from $191.00 to $173.00 and set an "overweight" rating for the company in a report on Tuesday, April 8th. Finally, Truist Financial decreased their price target on shares of Leidos from $165.00 to $155.00 and set a "buy" rating on the stock in a report on Monday, April 14th. Five research analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $179.23.

Insider Transactions at Leidos

In related news, Director Gary Stephen May sold 2,128 shares of the company's stock in a transaction that occurred on Tuesday, February 18th. The stock was sold at an average price of $131.24, for a total transaction of $279,278.72. Following the transaction, the director now directly owns 11,264 shares of the company's stock, valued at approximately $1,478,287.36. This represents a 15.89 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Robert C. Kovarik, Jr. sold 1,511 shares of Leidos stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $134.56, for a total transaction of $203,320.16. Following the completion of the sale, the director now directly owns 6,408 shares of the company's stock, valued at approximately $862,260.48. The trade was a 19.08 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 0.96% of the company's stock.

About Leidos

Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.